FDA Inspection 1270131 — Leslie L. Muldoon, Ph.D.

Leslie L. Muldoon, Ph.D. — FEI 3035154386

The FDA completed an inspection of Leslie L. Muldoon, Ph.D. on Apr 16, 2025 in Portland, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 16, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Portland, OR (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.